Trial Profile
A multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of estradiol [Evamist] metered-dose transdermal spray (MDTS) in the treatment of vasomotor symptoms in postmenopausal women
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2014
Price :
$35
*
At a glance
- Drugs Estradiol (Primary)
- Indications Hot flashes; Menopausal syndrome; Menopause; Vasomotor symptoms
- Focus Registrational; Therapeutic Use
- Sponsors Lumara Health
- 06 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 06 Jul 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 01 Jun 2008 Results have been published in Obstetrics and Gynecology.